Clin2
NCT06477952Possibly a fitRecruiting

Dronabinol for sleep apnea

Obstructive Sleep Apnea

Treatments studied

Part of Brain & nervous system, Lungs & breathing clinical trials.

This study tests whether dronabinol, a cannabis-like medicine, can help people with moderate sleep apnea breathe better at night. It may be an option for those who haven't found other treatments helpful.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
120 people
Ages
Up to 65 years
Study type
Interventional

Who can take part

  • You have moderate sleep apnea, shown by a recent sleep test, with a score between 15 and 50 events per hour.
  • You are not currently using a CPAP machine, mouthpiece, or tongue stimulator for sleep apnea, or you use them very little.
  • You have not had surgery for sleep apnea (except tonsil removal as a child).
  • You do not have severe lung problems, heart disease, kidney or liver disease, or a recent stroke.
  • You are not pregnant, not allergic to cannabis or sesame oil, and do not use illegal drugs or drink more than 10 alcoholic drinks weekly.
  • You are not a commercial driver or pilot, and you don't do shift work.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07570953Not yet recruiting· Phase 2/Phase 3
Sleep medicine for sleep apnea

This study tests a synthetic THC pill to see if it helps people with obstructive sleep apnea sleep better and use their CPAP machine more comfortably. THC is the active ingredient in cannabis, but this is a controlled medication.

Rochester, Minnesota
NCT07806851Not yet recruiting· Phase 3
Weight loss drug for sleep apnea with CPAP

This study tests an investigational medicine given as an injection to help people with obstructive sleep apnea and a high body mass index (BMI). It may reduce breathing pauses during sleep and support weight loss, all while you continue using your CPAP machine.

NCT03858751Recruiting· Phase 1/Phase 2
Drug to activate a sleep-control pathway for sleep apnea

This early study tests a medicine that is meant to improve how your brain and breathing muscles work during sleep for obstructive sleep apnea (OSA). If you qualify, you would be monitored during sleep to see whether the treatment changes breathing events and oxygen levels.

Boston, Massachusetts
NCT05293600Recruiting· Phase 1/Phase 2
Rescue medicine trial for sleep apnea after other treatments fail

This trial studies a “rescue” set of medicines for obstructive sleep apnea when two common treatments haven’t worked well enough. If you still have frequent breathing pauses during sleep, the study may test whether these medicines can reduce them and improve safety and symptoms.

Boston, Massachusetts
NCT06286189Recruiting· Phase 1/Phase 2
Testing trazodone for sleep apnea

This trial tests whether the medication trazodone can help people with moderate to severe obstructive sleep apnea (OSA). If you have OSA and are not taking certain medications or have other sleep disorders, you may be able to join.

Boston, Massachusetts
NCT06758596Not yet recruiting· Early Phase 1
Cannabis-like medicine and brain scans in young adults

This study looks at how a single dose of a cannabis-like medicine (dronabinol) affects the brain using brain scans (MRI and PET). It might help us learn more about how cannabis affects young adults who use it occasionally, which could guide future treatments for conditions like depression or chronic pain.

Chicago, Illinois

Hear when a new Obstructive Sleep Apnea trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.